Suppr超能文献

半乳糖凝集素在过敏性疾病中的作用。

Role of Galectins in Allergic Disorders.

作者信息

Kucuksezer Umut C, Ozdemir Cevdet

机构信息

Seher Yildizi Sokak 16/10 Etiler, 34337, Istanbul, Turkey.

出版信息

Recent Pat Inflamm Allergy Drug Discov. 2016;10(1):2-12. doi: 10.2174/1872213x10666160426152917.

Abstract

BACKGROUND

Allergen avoidance, pharmacotherapy; with antihistamines, anti-leukotrienes, corticosteroids and bronchodilators.as well as monoclonal antibodies; and allergen specific immunotherapy stand as confirmed approaches for the management of allergic disorders as asthma, allergic rhinitis/rhinoconjunctivitis, atopic dermatitis, food allergies and anaphylaxis. Galectins are members of animal lectin protein family, with binding specificity for β-galactoside sugars. These highly conserved proteins are known to be expressed in various effector cells of the immune system, exert immuno-regulatory activities, and enroll in tissue inflammation and regulation of immune homeostasis.

OBJECTIVE

This review aims to explain the galectin family and influence of galectins in the immune mechanisms of allergic disorders.

RESULTS

Galectins have multiple roles in innate and adaptive immunity. Intense research in the field of immunology related with galectins have given rise to several patent applications. Those, increasing in vivo efficacy of galectins for therapeutic applications, utilizing galectins for immune stimulation and prolongation of immune responses, utilization of them as disease markers are pioneers. As immune cells can be targeted by galectins, cells containing these molecules can be used for immune intervention. Regulation of cytokine productions by immune cells as IL-1β and IL-10 as well as dendritic cell functions by galectins may be efficient in limitation of some immune-mediated disorders.

CONCLUSION

Taken all together, better learning of galectin biology together with detailed revealing of galectin-immune system interactions have great potential for immune interventions targeting allergy-related disorders.

摘要

背景

避免接触过敏原、药物治疗(使用抗组胺药、抗白三烯药、皮质类固醇和支气管扩张剂以及单克隆抗体)以及过敏原特异性免疫疗法是治疗哮喘、过敏性鼻炎/鼻结膜炎、特应性皮炎、食物过敏和过敏反应等过敏性疾病的公认方法。半乳糖凝集素是动物凝集素蛋白家族的成员,对β-半乳糖苷糖具有结合特异性。已知这些高度保守的蛋白质在免疫系统的各种效应细胞中表达,发挥免疫调节活性,并参与组织炎症和免疫稳态的调节。

目的

本综述旨在解释半乳糖凝集素家族及其在过敏性疾病免疫机制中的影响。

结果

半乳糖凝集素在先天性和适应性免疫中具有多种作用。在与半乳糖凝集素相关的免疫学领域的深入研究已经产生了几项专利申请。其中,提高半乳糖凝集素在治疗应用中的体内疗效、利用半乳糖凝集素进行免疫刺激和延长免疫反应、将它们用作疾病标志物是先驱。由于免疫细胞可被半乳糖凝集素靶向,含有这些分子的细胞可用于免疫干预。半乳糖凝集素对免疫细胞产生细胞因子(如白细胞介素-1β和白细胞介素-10)的调节以及对树突状细胞功能的调节可能对限制某些免疫介导的疾病有效。

结论

综上所述,更好地了解半乳糖凝集素生物学以及详细揭示半乳糖凝集素与免疫系统的相互作用对于针对过敏相关疾病的免疫干预具有巨大潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验